150 related articles for article (PubMed ID: 18083556)
1. Inhibition of tubulin polymerization by select alkenyldiarylmethanes.
Cullen MD; Sarkar T; Hamel E; Hartman TL; Watson KM; Buckheit RW; Pannecouque C; De Clercq E; Cushman M
Bioorg Med Chem Lett; 2008 Jan; 18(2):469-73. PubMed ID: 18083556
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors.
Cullen MD; Cheung YF; Houslay MD; Hartman TL; Watson KM; Buckheit RW; Pannecouque C; De Clercq E; Cushman M
Bioorg Med Chem Lett; 2008 Feb; 18(4):1530-3. PubMed ID: 18222088
[TBL] [Abstract][Full Text] [Related]
3. The biological effects of structural variation at the meta position of the aromatic rings and at the end of the alkenyl chain in the alkenyldiarylmethane series of non-nucleoside reverse transcriptase inhibitors.
Xu G; Micklatcher M; Silvestri MA; Hartman TL; Burrier J; Osterling MC; Wargo H; Turpin JA; Buckheit RW; Cushman M
J Med Chem; 2001 Nov; 44(24):4092-113. PubMed ID: 11708913
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, anti-HIV activities, and metabolic stabilities of alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors.
Silvestri MA; Nagarajan M; De Clercq E; Pannecouque C; Cushman M
J Med Chem; 2004 Jun; 47(12):3149-62. PubMed ID: 15163195
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HIV activity of new alkenyldiarylmethane (ADAM) non-nucleoside reverse transcriptase inhibitors (NNRTIs) incorporating benzoxazolone and benzisoxazole rings.
Deng BL; Cullen MD; Zhou Z; Hartman TL; Buckheit RW; Pannecouque C; De Clercq E; Fanwick PE; Cushman M
Bioorg Med Chem; 2006 Apr; 14(7):2366-74. PubMed ID: 16321539
[TBL] [Abstract][Full Text] [Related]
6. Novel modifications in the alkenyldiarylmethane (ADAM) series of non-nucleoside reverse transcriptase inhibitors.
Casimiro-Garcia A; Micklatcher M; Turpin JA; Stup TL; Watson K; Buckheit RW; Cushman M
J Med Chem; 1999 Nov; 42(23):4861-74. PubMed ID: 10579849
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of methyl ester bioisosteres in the context of developing alkenyldiarylmethanes (ADAMs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) for anti-HIV-1 chemotherapy.
Hoshi A; Sakamoto T; Takayama J; Xuan M; Okazaki M; Hartman TL; Buckheit RW; Pannecouque C; Cushman M
Bioorg Med Chem; 2016 Jul; 24(13):3006-3022. PubMed ID: 27234889
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
Zhang SX; Bastow KF; Tachibana Y; Kuo SC; Hamel E; Mauger A; Narayanan VL; Lee KH
J Med Chem; 1999 Oct; 42(20):4081-7. PubMed ID: 10514278
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic study of a novel subnanomolar inhibitor provides insight on the binding interactions of alkenyldiarylmethanes with human immunodeficiency virus-1 reverse transcriptase.
Cullen MD; Ho WC; Bauman JD; Das K; Arnold E; Hartman TL; Watson KM; Buckheit RW; Pannecouque C; De Clercq E; Cushman M
J Med Chem; 2009 Oct; 52(20):6467-73. PubMed ID: 19775161
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, anti-HIV activity, and metabolic stability of new alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors.
Deng BL; Hartman TL; Buckheit RW; Pannecouque C; De Clercq E; Fanwick PE; Cushman M
J Med Chem; 2005 Sep; 48(19):6140-55. PubMed ID: 16162014
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of alkenyldiarylmethane (ADAM) non-nucleoside HIV-1 reverse transcriptase inhibitors with non-identical aromatic rings.
Xu G; Hartman TL; Wargo H; Turpin JA; Buckheit RW; Cushman M
Bioorg Med Chem; 2002 Feb; 10(2):283-90. PubMed ID: 11741777
[TBL] [Abstract][Full Text] [Related]
12. The effect of exchanging various substituents at the 2-position of 2-methoxyestradiol on cytotoxicity in human cancer cell cultures and inhibition of tubulin polymerization.
Cushman M; Mohanakrishnan AK; Hollingshead M; Hamel E
J Med Chem; 2002 Oct; 45(21):4748-54. PubMed ID: 12361402
[TBL] [Abstract][Full Text] [Related]
13. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV activity of new metabolically stable alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors incorporating N-methoxy imidoyl halide and 1,2,4-oxadiazole systems.
Sakamoto T; Cullen MD; Hartman TL; Watson KM; Buckheit RW; Pannecouque C; De Clercq E; Cushman M
J Med Chem; 2007 Jul; 50(14):3314-21. PubMed ID: 17579385
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW
J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
Mu F; Hamel E; Lee DJ; Pryor DE; Cushman M
J Med Chem; 2003 Apr; 46(9):1670-82. PubMed ID: 12699385
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase synthesis of the alkenyldiarylmethane (ADAM) series of non-nucleoside HIV-1 reverse transcriptase inhibitors.
Xu G; Loftus TL; Wargo H; Turpin JA; Buckheit RW; Cushman M
J Org Chem; 2001 Sep; 66(18):5958-64. PubMed ID: 11529718
[TBL] [Abstract][Full Text] [Related]
18. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
19. 6-Alkylamino- and 2,3-dihydro-3'-methoxy-2-phenyl-4-quinazolinones and related compounds: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
Hour MJ; Huang LJ; Kuo SC; Xia Y; Bastow K; Nakanishi Y; Hamel E; Lee KH
J Med Chem; 2000 Nov; 43(23):4479-87. PubMed ID: 11087572
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Deng BL; Zhao Y; Hartman TL; Watson K; Buckheit RW; Pannecouque C; De Clercq E; Cushman M
Eur J Med Chem; 2009 Mar; 44(3):1210-4. PubMed ID: 18952324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]